BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help

Documents 1-25 out of 116 found
  Current Search:  restasis: 151, cyclosporine: 1022  

100%
PDF
Microsoft Word - RESTASIS PI Feb 04.doc
Cyclosporine's chemical name is Cyclo[[( E)-( 2S, 3R, 4R)- 3- hydroxy- 4- methyl- 2-( methylamino)- 6- octenoyl]- L- 2- aminobutyryl- N- methylglycylN- methyl- L- leucyl- L- valyl- N- methyl- L- leucyl- L- alanyl- D- alanyl- N- methyl- L- leucyl- N- methyl- L- leucyl- N- methyl- L- valyl] and it has the following structure: Cyclosporine is a fine white powder.
CLINICAL...

author: tran_ynhu
Matching: restasis cyclosporine Find similar documents More document info

100%
PDF
Microsoft Word - RESTASIS PI Feb 04.doc page 2


author: tran_ynhu
Matching: restasis cyclosporine Find similar documents More document info

100%
PDF
Microsoft Word - RESTASIS PI Feb 04.doc page 1


author: tran_ynhu
Matching: restasis cyclosporine Find similar documents More document info

100%
HTML
Cyclosporine ophthalmic for Sjoegren's syndrome - [Medication] - Quest Diagnostics Patient Health Library
Cyclosporine ophthalmic for Sjoegren's syndrome Examples Brand Name Chemical Name Restasis cyclosporine How It Works Cyclosporine is an immunosuppressive medication that decreases the action of your body's immune system.
Cyclosporine ophthalmic is used in eyedrop form to treat Sjoegren's syndrome , a disease that causes dry eyes and mouth.
...
Matching: restasis cyclosporine Find similar documents More document info
100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN PHENAPHEN-650 W/ CODEINE, ACETAMINOPHEN PHENAZINE, PHENDIMETRAZINE TARTRATE PHENAZINE-35, PHENDIMETRAZINE TARTRATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENERGAN FORTIS, PROMETHAZINE HYDROCHLORIDE PHENERGAN PLAIN, PROMETHAZINE HYDROCHLORIDE PHENERGAN VC W/ CODEINE, CODEINE PHOSPHATE PHENERGAN VC, PHENYLEPHRINE HYDROCHLORIDE PHENERGAN W/ CODEINE, CODEINE...

Matching: restasis cyclosporine Find similar documents More document info
100%
HTML
CDER 2002 Report to the Nation; Drug Review
Food and Drug Administration • Center for Drug Evaluation and Research About CDER - Report Search CDER Report to the Nation: 2002 Table of Contents Adobe Acrobat version of this document 1 Drug Review Index Mission Highlights New Drug Review List of priority new drugs List of new molecular entities List of orphan new drugs New Drug Review Statistics Priority new drug statistics...
author: OLIVERN
Matching: Find similar documents More document info
100%
HTML
Prescription and Over-the-Counter Drug Product List: 3/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
Matching: restasis cyclosporine Find similar documents More document info
100%
PDF
C:\LORI\ALLERGAN\50790 slr001 AP ltr vial statement 8-8-03.doc
NDA 50- 790/ S- 001 Page 3 RESTASIS (cyclosporine ophthalmic emulsion) 0.05% Sterile, Preservative- Free DESCRIPTION RESTASIS (cyclosporine ophthalmic emulsion) 0.05% contains a topical immunomodulator with anti- inflammatory effects
INDICATIONS AND USAGE RESTASIS ophthalmic emulsion is indicated to increase tear production in patients whose tear production is...

author: Lori Gorski
Matching: restasis cyclosporine Find similar documents More document info

100%
PDF
C:\LORI\ALLERGAN\50790 slr001 AP ltr vial statement 8-8-03.doc page 4


author: Lori Gorski
Matching: restasis cyclosporine Find similar documents More document info

100%
PDF
C:\LORI\ALLERGAN\50790 slr001 AP ltr vial statement 8-8-03.doc page 3


author: Lori Gorski
Matching: restasis cyclosporine Find similar documents More document info

100%
PDF
C:\LORI\ALLERGAN\50790 slr001 AP ltr vial statement 8-8-03.doc page 1


author: Lori Gorski
Matching: restasis cyclosporine Find similar documents More document info

100%
PDF
C:\LORI\ALLERGAN\21023 AP ltr 12-23-02 with label final.doc
NDA 21- 023 Page 3 RESTASIS (cyclosporine ophthalmic emulsion) 0.05% Sterile, Preservative- Free DESCRIPTION RESTASIS (cyclosporine ophthalmic emulsion) 0.05% contains a topical immunomodulator with anti- inflammatory effects
No increase in bacterial or fungal ocular infections was reported following administration of RESTASIS
NDA 21- 023 Page 5 RESTASIS...

author: Lori Gorski
Matching: restasis cyclosporine Find similar documents More document info

100%
PDF
C:\LORI\ALLERGAN\21023 AP ltr 12-23-02 with label final.doc page 4


author: Lori Gorski
Matching: restasis cyclosporine Find similar documents More document info

100%
PDF
C:\LORI\ALLERGAN\21023 AP ltr 12-23-02 with label final.doc page 3


author: Lori Gorski
Matching: restasis cyclosporine Find similar documents More document info

100%
PDF
C:\LORI\ALLERGAN\21023 AP ltr 12-23-02 with label final.doc page 1


author: Lori Gorski
Matching: restasis cyclosporine Find similar documents More document info

100%
HTML
Prescription and OTC Drug Product List 12/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACARBOSE TABLET; ORAL PRECOSE -D- BAYER 25MG N20482 004 MAY 29, 1997 DEC CAHN -D- 50MG N20482 001 SEP 06, 1995 DEC CAHN -D- + 100MG N20482 002 SEP 06, 1995 DEC CAHN -A- BAYER PHARMS 25MG N20482 004 MAY 29, 1997 DEC CAHN -A- 50MG N20482 001 SEP 06, 1995 DEC CAHN -A- + 100MG N20482 002 SEP 06, 1995 DEC CAHN ACYCLOVIR -A- CREAM;...
Matching: restasis cyclosporine Find similar documents More document info
56%
HTML
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Matching: restasis Find similar documents More document info
56%
HTML
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Matching: restasis Find similar documents More document info
56%
HTML
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Matching: restasis Find similar documents More document info
56%
HTML
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Matching: restasis Find similar documents More document info
56%
HTML
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Matching: restasis Find similar documents More document info
56%
HTML
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Matching: restasis Find similar documents More document info
56%
HTML
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Matching: restasis Find similar documents More document info
56%
HTML
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Matching: restasis Find similar documents More document info
56%
HTML
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Matching: restasis Find similar documents More document info

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.